GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (XSWX:ABT) » Definitions » Long-Term Debt

Abbott Laboratories (XSWX:ABT) Long-Term Debt : CHF11,175 Mil (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Abbott Laboratories Long-Term Debt?

Abbott Laboratories's Long-Term Debt for the quarter that ended in Mar. 2024 was CHF11,175 Mil.

Abbott Laboratories's quarterly Long-Term Debt declined from Sep. 2023 (CHF13,024 Mil) to Dec. 2023 (CHF11,760 Mil) and declined from Dec. 2023 (CHF11,760 Mil) to Mar. 2024 (CHF11,175 Mil).

Abbott Laboratories's annual Long-Term Debt declined from Dec. 2021 (CHF15,930 Mil) to Dec. 2022 (CHF13,529 Mil) and declined from Dec. 2022 (CHF13,529 Mil) to Dec. 2023 (CHF11,760 Mil).


Abbott Laboratories Long-Term Debt Historical Data

The historical data trend for Abbott Laboratories's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Long-Term Debt Chart

Abbott Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16,371.10 16,459.39 15,929.62 13,528.70 11,760.42

Abbott Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,526.18 13,111.63 13,023.51 11,760.42 11,175.03

Abbott Laboratories  (XSWX:ABT) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Abbott Laboratories Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (XSWX:ABT) Business Description

Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Abbott Laboratories (XSWX:ABT) Headlines

From GuruFocus

Q3 2020 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2019 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2020 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2022 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2021 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2019 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2021 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024